Abstract
Objective To investigate the antigen-specific T cell functionality in type 2 diabetes mellitus patients. Methods Peripheral blood from 38 type 2 diabetes mellitus patients and 47 health controls (control group) have been collected. The proportions of CD4+ and CD8+ T cell as well as the ratio of CD4+ /CD8+ were monitored by flow cytometry. Meanwhile, antigen- nonspecific and specific Th1 responses were compared between two groups through detecting interferon (IFN)-γ, interleukin 2 (IL-2), and tumor necrosis factor (TNF)-α producing cells upon propylene glycol monomethyl ether acetate (PMA)/ionomycine and epstein-barr virus (EBV) peptides stimulation, respectively followed by an intracellular cytokine staining. Results Compared to control group, the proportion of CD4+ T cell and the ratio of CD4+ /CD8+ were significantly increased in type 2 diabetes mellitus group (P<0.05) whereas CD8+ T cells exhibited no significant difference between two groups. Antigen-nonspecific Th1 responses in type 2 diabetes mellitus patients were significantly decreased, demonstrated by lower percentages of IFN-γ, IL-2, and TNF-α producing CD4+ T cells when compared to control group , while CD8+ T cells in type 2 diabetes mellitus patients exhibited similar cytokine production patterns. However, when stimulated by EBV specific peptides, the percentages of IFN-γ, IL-2, and TNF-α producing CD8+ T cells were significantly higher in type 2 diabetes mellitus patients than those in control group (P<0.05). HbA1C was positively correlated with the percentage of EBV-specific TNF-α producing CD8+ T cells (P<0.05). Conclusion In type 2 diabetes mellitus, the secretion capacity of CD4+ and CD8+ T cell was significantly decreased and the antigen-specific responses represent the presence of an abnormal activated status, which indicates that chronic hyperglycemia may damage T cells function and aggravate chronic inflammation. (Chin J Endocrinol Metab, 2018, 34: 761-767) Key words: Diabetes mellitus, type 2; Antigen-specific T cell responses; CD4+ T cells; CD8+ T cells; Cytokine
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
